BLGO vs. SLI, LXFR, ARQ, VGAS, ADUR, ZTEK, TSE, ORGN, AMTX, and ALTO
Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Standard Lithium (SLI), Luxfer (LXFR), ARQ (ARQ), Verde Clean Fuels (VGAS), Aduro Clean Technologies (ADUR), Zentek (ZTEK), Trinseo (TSE), Origin Materials (ORGN), Aemetis (AMTX), and Alto Ingredients (ALTO). These companies are all part of the "chemicals" industry.
BioLargo vs.
Standard Lithium (NYSE:SLI) and BioLargo (NASDAQ:BLGO) are both small-cap energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability.
BioLargo received 109 more outperform votes than Standard Lithium when rated by MarketBeat users. However, 100.00% of users gave Standard Lithium an outperform vote while only 60.99% of users gave BioLargo an outperform vote.
Standard Lithium has a net margin of 0.00% compared to BioLargo's net margin of -11.45%. Standard Lithium's return on equity of -11.52% beat BioLargo's return on equity.
Standard Lithium currently has a consensus target price of $3.95, suggesting a potential upside of 172.41%. Given Standard Lithium's stronger consensus rating and higher probable upside, research analysts clearly believe Standard Lithium is more favorable than BioLargo.
In the previous week, Standard Lithium and Standard Lithium both had 1 articles in the media. Standard Lithium's average media sentiment score of 1.09 beat BioLargo's score of 0.75 indicating that Standard Lithium is being referred to more favorably in the media.
16.8% of Standard Lithium shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 3.7% of Standard Lithium shares are held by company insiders. Comparatively, 20.3% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Standard Lithium has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, BioLargo has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500.
Standard Lithium has higher earnings, but lower revenue than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than Standard Lithium, indicating that it is currently the more affordable of the two stocks.
Summary
Standard Lithium beats BioLargo on 13 of the 16 factors compared between the two stocks.
Get BioLargo News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioLargo Competitors List
Related Companies and Tools
This page (NASDAQ:BLGO) was last updated on 5/1/2025 by MarketBeat.com Staff
